OSI-930 penem monohydrate The effective concentration-50% (EC50) of

The effective concentration-50% (EC50) of GS 441524 is calculated to be 0

assesses after 6 days) inhibits TGF-β1-mediated proliferation of familial idiopathic pulmonary arterial hypertension (iPAH) pulmonary artery smooth muscle cells (PASMCs) at an IC50 of 295 nM

IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma

and also to prevent phosphorylation of Smad2/3 and the growth inhibition induced by TGF-beta

OSI-930 penem monohydrate The effective concentration-50% (EC50) ofOSI 930 is a selective thiophene derived tyrosine kinase inhibitor with potential antineoplastic activity. Tyrosine kinase inhibitor OSI 930 inhibits stem cell factor receptor (c Kit) and the vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of both tumor cell proliferation and tumor angiogenesis. Both c Kit and VEGFR2 are overexpressed in a variety of cancers. Check for active clinical trials or closed